Literature DB >> 10969140

Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats.

K Jacke1, K Witte, L Huser, S Behrends, B Lemmer.   

Abstract

Soluble guanylyl cyclase activity and its stimulation by diethylamineNONOate was measured in aortae from hypertensive TGR(mREN2)27 rats (TGR) and Sprague-Dawley controls. Superoxide dismutase was added in vitro to evaluate the contribution of oxidative breakdown of nitric oxide (NO) by superoxide anions. Expression of soluble guanylyl cyclase was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR). Basal and stimulated soluble guanylyl cyclase activity was significantly reduced in TGR rats, addition of superoxide dismutase had no effect. Expression of soluble guanylyl cyclase subunits was not different between strains. The independent contribution of hypertension and the overactive renin-angiotensin system to soluble guanylyl cyclase subsensitivity was assessed after normalization of TGR's blood pressure by the Ca(2+)-channel blocker amlodipine or the angiotensin converting enzyme-inhibitor enalapril. Soluble guanylyl cyclase activity in TGR was slightly increased by amlodipine and almost completely restored by enalapril. In conclusion, TGR showed desensitized vascular soluble guanylyl cyclase, depending on their overactive renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969140     DOI: 10.1016/s0014-2999(00)00577-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.

Authors:  Pierre-Antoine Crassous; Samba Couloubaly; Can Huang; Zongmin Zhou; Padmamalini Baskaran; David D Kim; Andreas Papapetropoulos; Xavier Fioramonti; Walter N Durán; Annie Beuve
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

2.  Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.

Authors:  Virgínia S Lemos; Steyner F Côrtes; Denise M R Silva; Maria J Campagnole-Santos; Robson A S Santos
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.

Authors:  Emmanuel S Buys; Michael J Raher; Andrew Kirby; Mohd Shahid; Shahid Mohd; David M Baron; Sarah R Hayton; Laurel T Tainsh; Patrick Y Sips; Kristen M Rauwerdink; Qingshang Yan; Robert E T Tainsh; Hannah R Shakartzi; Christine Stevens; Kelly Decaluwé; Maria da Gloria Rodrigues-Machado; Rajeev Malhotra; Johan Van de Voorde; Tong Wang; Peter Brouckaert; Mark J Daly; Kenneth D Bloch
Journal:  J Clin Invest       Date:  2012-05-08       Impact factor: 14.808

4.  Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway.

Authors:  Catarina Rippe; Baoyi Zhu; Katarzyna K Krawczyk; Ed Van Bavel; Sebastian Albinsson; Jonas Sjölund; Erik N T P Bakker; Karl Swärd
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

5.  Differential effects of long-term slow-pressor and subpressor angiotensin II on contractile and relaxant reactivity of resistance versus conductance arteries.

Authors:  Phillip G Kopf; Laura E Phelps; Chad D Schupbach; Alan K Johnson; Jacob D Peuler
Journal:  Physiol Rep       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.